Page last updated: 2024-08-22

lutetium and Leukemia, Myeloid, Acute

lutetium has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Alapati, N; Ali, AZ; Digumarti, R; Manasa, N; Vallathol, DH; Vasanth, P	1
Baum, RP; Bodei, L; Cremonesi, M; Drozdov, I; Grana, CM; Kidd, M; Krenning, EP; Kwekkeboom, DJ; Lepensky, C; Modlin, IM; Paganelli, G	1

Trials

1 trial(s) available for lutetium and Leukemia, Myeloid, Acute

Article	Year
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Leukemia, Myeloid, Acute; Lutetium; Male; Middle Aged; Myelodysplastic Syndromes; Neuroendocrine Tumors; Octreotide; Radiation Dosage; Radiopharmaceuticals; Receptors, Peptide; Yttrium Radioisotopes	2015

Article

Year

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.

European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Leukemia, Myeloid, Acute; Lutetium; Male; Middle Aged; Myelodysplastic Syndromes; Neuroendocrine Tumors; Octreotide; Radiation Dosage; Radiopharmaceuticals; Receptors, Peptide; Yttrium Radioisotopes

2015

Other Studies

1 other study(ies) available for lutetium and Leukemia, Myeloid, Acute

Article	Year
Lutetium 177 dotatate induced acute myeloid leukemia. Leukemia & lymphoma, 2020, Volume: 61, Issue:13 Topics: Humans; Leukemia, Myeloid, Acute; Lutetium; Neuroendocrine Tumors; Radiopharmaceuticals	2020